American pharmaceutical company Moderna’s chief medical officer Paul Burton has announced that a vaccine against the COVID-19 omicron mutation could be launched early next year.
CMO Burton appeared on the BBC on the 28th local time and said, “We will have to find out if the current vaccine is capable of preventing it in the next two weeks.” said.
He said there are important questions about the current Omicron mutation, such as whether it is more contagious, how serious it causes symptoms, and whether it can be controlled with a current vaccine. explained that this would take.
Then, when asked whether Omicron can evade the current vaccine, he said, “Of the 30 mutations identified in the spike protein, 9 were found to be related to immune evasion, and 11 are believed to be related,” he said. answered.
He also emphasized that the moderna vaccine will be able to respond quickly, saying that the work will start to confirm the effectiveness of the existing vaccine to prevent omicron mutation, and the results will be available within two weeks.
“The message of the omicron mutation is that if you haven’t been vaccinated, you should get the vaccine right now,” added Burton.